GGrantIndex
← Search

PHASE I/II TRIAL OF AMIFOSTINE, HIGH DOSE CISPLATIN, AND DOCETAXEL IN NSCLC

$12,855M01FY2001RRNIH

University Of Wisconsin Madison, Madison WI

Investigators

Linked publications & trials

View original record on NIH RePORTER →